130 related articles for article (PubMed ID: 22827228)
1. The role of eosinophil cationic protein (ECP) and histamine in vernal keratoconjunctivitis.
Secchi A; Leonardi A; Abelson M
Ocul Immunol Inflamm; 1995; 3(1):23-8. PubMed ID: 22827228
[TBL] [Abstract][Full Text] [Related]
2. Histaminase activity in patients with vernal keratoconjunctivitis.
Abelson MB; Leonardi AA; Smith LM; Fregona IA; George MA; Secchi AG
Ophthalmology; 1995 Dec; 102(12):1958-63. PubMed ID: 9098303
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis.
Leonardi A; Borghesan F; Faggian D; Secchi A; Plebani M
Allergy; 1995 Jul; 50(7):610-3. PubMed ID: 8588697
[TBL] [Abstract][Full Text] [Related]
4. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
Leonardi A; Borghesan F; Avarello A; Plebani M; Secchi AG
Br J Ophthalmol; 1997 Jan; 81(1):23-6. PubMed ID: 9135403
[TBL] [Abstract][Full Text] [Related]
5. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry.
Leonardi A; DeFranchis G; Zancanaro F; Crivellari G; De Paoli M; Plebani M; Secchi AG
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3036-40. PubMed ID: 10549670
[TBL] [Abstract][Full Text] [Related]
6. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
Oray M; Toker E
Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
[TBL] [Abstract][Full Text] [Related]
7. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
Akman A; Irkeç M; Orhan M
Eye (Lond); 1998; 12 ( Pt 2)():291-5. PubMed ID: 9683957
[TBL] [Abstract][Full Text] [Related]
8. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
Leonardi A; Jose PJ; Zhan H; Calder VL
Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis.
Shoji J; Inada N; Sawa M
Jpn J Ophthalmol; 2009 Mar; 53(2):92-99. PubMed ID: 19333691
[TBL] [Abstract][Full Text] [Related]
10. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.
Uchio E; Ono SY; Ikezawa Z; Ohno S
Clin Exp Allergy; 2000 Jan; 30(1):103-9. PubMed ID: 10606937
[TBL] [Abstract][Full Text] [Related]
11. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
Hu Y; Matsumoto Y; Dogru M; Okada N; Igarashi A; Fukagawa K; Tsubota K; Fujishima H
Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
[TBL] [Abstract][Full Text] [Related]
12. Clinical Usefulness of Simultaneous Measurement of the Tear Levels of CCL17, CCL24, and IL-16 for the Biomarkers of Allergic Conjunctival Disorders.
Shoji J; Aso H; Inada N
Curr Eye Res; 2017 May; 42(5):677-684. PubMed ID: 27897453
[TBL] [Abstract][Full Text] [Related]
13. Tear chymase in vernal keratoconjunctivitis.
Ebihara N; Funaki T; Takai S; Miyazaki M; Fujiki K; Murakami A
Curr Eye Res; 2004 Jun; 28(6):417-20. PubMed ID: 15512949
[TBL] [Abstract][Full Text] [Related]
14. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms.
Pucci N; Novembre E; Lombardi E; Cianferoni A; Bernardini R; Massai C; Caputo R; Campa L; Vierucci A
Clin Exp Allergy; 2003 Mar; 33(3):325-30. PubMed ID: 12614446
[TBL] [Abstract][Full Text] [Related]
15. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.
Leonardi A; Brun P; Abatangelo G; Plebani M; Secchi AG
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3052-8. PubMed ID: 12824251
[TBL] [Abstract][Full Text] [Related]
16. [Allergy related factors in tears of patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment].
Hori S; Shoji J; Inada N; Sawa M
Nippon Ganka Gakkai Zasshi; 2011 Dec; 115(12):1079-85. PubMed ID: 22312812
[TBL] [Abstract][Full Text] [Related]
17. IgE and eosinophil cationic protein (ECP) as markers of severity in the diagnosis of atopic keratoconjunctivitis.
Wakamatsu TH; Satake Y; Igarashi A; Dogru M; Ibrahim OM; Okada N; Fukagawa K; Shimazaki J; Fujishima H
Br J Ophthalmol; 2012 Apr; 96(4):581-6. PubMed ID: 22275342
[TBL] [Abstract][Full Text] [Related]
18. Trypsin inhibitory capacity in vernal keratoconjunctivitis.
Ghavami S; Hashemi M; de Serres FJ; Bajestani SN; Mehrabifar H; Leonardi A
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):264-9. PubMed ID: 17197542
[TBL] [Abstract][Full Text] [Related]
19. [Activated eosinophils in vernal keratoconjunctivitis].
Saiga T; Shimizu Y
Nihon Rinsho; 1993 Mar; 51(3):816-9. PubMed ID: 8492463
[TBL] [Abstract][Full Text] [Related]
20. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
